Do anti-angiogenic cancer therapies increase risk of significant weight loss?

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.4, 2014-04, pp. : 473-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-Angiogenic Therapies for Children with Cancer

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 879-889

Bentham Science Publishers

Access to resources Recommend Favorite

Current status and future prospects for anti-angiogenic therapies in cancer

By Staton Carolyn A Brown Nicola J Reed Malcolm WR

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 961-979

Informa Healthcare

Access to resources Recommend Favorite

Anti-angiogenic therapies for malignant pleural mesothelioma

By Ceresoli Giovanni Luca Zucali Paolo Andrea

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 833-844

Informa Healthcare

Access to resources Recommend Favorite

Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 1025-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite